Zejula 200 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FGBBD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $47,176
Award facts
- Contract value 100% obligated
- $47,176.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at approximately $47.2K by the Defense Logistics Agency (DLA) on September 22, 2025, for the supply of Zejula 200 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 14, 2025. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceuticals and medical supplies to support military healthcare programs globally.
The award reflects AmerisourceBergen's established role as a critical federal medical procurement vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Zejula (niraparib), a specialized oncology medication, represents the type of brand-name pharmaceutical product within the company's extensive portfolio of therapeutic solutions. As a child contract under the larger DLA Troop Support Medical IDC, this delivery order demonstrates the operational efficiency of the indefinite delivery contract vehicle in responding to federal medical supply requirements on a time-sensitive basis.
Quick answers
Who was awarded contract SPE2DB25FGBBD?
SPE2DB25FGBBD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FGBBD worth?
The government has obligated $47,176 on SPE2DB25FGBBD.
Is contract SPE2DB25FGBBD an order under another contract?
Yes. SPE2DB25FGBBD is a delivery order under SPE2DB24D3015, an indefinite delivery contract.
Was contract SPE2DB25FGBBD competed?
The extent of competition for SPE2DB25FGBBD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award